You are here

The Progress Report Keep up-to-date with our community. From science coverage to fundraiser spotlights, get the latest news here.

As tumors develop and grow, individual tumor cells acquire the ability to adapt to changes in the environment that would normally kill the tumor cells. One way they do this is to trick the immune system.

The Breast Cancer Research Foundation has appointed Judy E. Garber, MD, MPH, of Dana-Farber Cancer Institute and Harvard Medical School, as its new Scientific Advisory Board Chairman.

The discovery of the BRCA1 and BRCA2 genes more than 20 years ago dramatically changed risk assessment, prevention and treatment in families with a high prevalence of breast and/or ovarian cancers.

How tennis and a pair of shoes helped 25-year breast cancer survivor reclaim her passion post-treatment
Boston native sits down with BCRF to kick off Women’s Health Week
BCRF's Dr. Margaret Flowers Recaps the Annual Conference
Tags: